Teitell: How immunotherapy became the fourth pillar of cancer care at UCLA

NCI needs a $250M raise in FY24 to maintain paylines, grant funding levels amid crippling continuing resolutions

The gridlock in Washington is taking a toll on federally funded cancer research as the partisan wrangling in Congress over border security and funding for Israel and Ukraine shows no sign of relenting.

December 01, 2023

Vol.49 No.44

By Matthew Bin Han Ong

Vinay Prasad describes his Vanderbilt colleagues as “despicable,” raising new questions about physicians’ conduct on social media

At a time when distinguished careers can falter because of a careless Facebook post, the oncologist-iconoclast Vinay Prasad is showing no sign of moderating the shaming and haranguing that make him a social media phenom.

December 01, 2023

Vol.49 No.44

By Paul Goldberg

Conversation with The Cancer Letter

Prasad could not have had patient data when he called Vanderbilt colleagues “despicable”

Vinay Prasad, a social media phenom and professor of epidemiology and biostatistics at the University of California, San Francisco, recently stunned his colleagues by stating that doctors at Vanderbilt University acted in a “despicable” manner when they offered a double lung transplant to a lung cancer patient. “The doctors at Vanderbilt are despicable in my...

December 01, 2023

Vol.49 No.44

By Paul Goldberg

Alec Kimmelman named director of Perlmutter Cancer Center, quickly replacing ousted Benjamin Neel

Alec Kimmelman was named director of the Laura and Isaac Perlmutter Cancer Center, effective immediately.

December 01, 2023

Vol.49 No.44

By Alexandria Carolan

Guest Editorial

For cancer patients, traditional Medicare is better than Medicare Advantage

Now that the Medicare re-enrollment period has arrived (Oct. 15-Dec. 7), senior Americans are exposed to ubiquitous advertisements, phone calls, and other mechanisms to convince them to enroll in Medicare Advantage rather than traditional Medicare plans.

December 01, 2023

Vol.49 No.44

By Hagop M. Kantarjian and Mary Alma Welch

Obituary

Worta McCaskill-Stevens understood the importance of explaining cancer prevention

Worta McCaskill-Stevens, MD, died on Nov. 15 from complications from a sarcoma. She was 74.

December 01, 2023

Vol.49 No.44

By Otis W. Brawley and Lucile L. Adams-Campbell

Teitell: How immunotherapy became the fourth pillar of cancer care at UCLA

YOU MAY BE INTERESTED IN

NCI needs a $250M raise in FY24 to maintain paylines, grant funding levels amid crippling continuing resolutions

Vinay Prasad describes his Vanderbilt colleagues as “despicable,” raising new questions about physicians’ conduct on social media

Prasad could not have had patient data when he called Vanderbilt colleagues “despicable”

Alec Kimmelman named director of Perlmutter Cancer Center, quickly replacing ousted Benjamin Neel

For cancer patients, traditional Medicare is better than Medicare Advantage

Worta McCaskill-Stevens understood the importance of explaining cancer prevention

Renew today!

Subscriber content

Login